1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow pegylated interferon: new trials by email Literature Review of pegylated interferon trials Research Report on pegylated interferon
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Standard of Care (SOC) With or Without CTS-1027 in Hepatitis C (HCV) Null-Responders CTS-1027, pegylated interferon, Ribavirin - Hepatitis C | Phase 2 | Terminated | Conatus Pharmaceuticals Inc. | 114 | 2011-01-01 | 2012-06-11 |
Hepatitis C (1)
Conatus Pharmaceuticals Inc. (1)
United States (1)